Post-treatment Levels of α-Fetoprotein Predict Incidence of Hepatocellular Carcinoma After Interferon Therapy

Tsugiko Oze, Naoki Hiramatsu, Takayuki Yakushijin, +24

Clinical Gastroenterology and Hepatology

Post-treatment LevelsHepatologyMedicineLiver PhysiologyPathology +10

Suppression of hepatocellular carcinoma development in hepatitis <scp>C</scp> patients given interferon‐based antiviral therapy

Naoki Hiramatsu, Tsugiko Oze, Tetsuo Takehara

Hepatology Research

ImmunologyPathologyChronic Hepatitis CCirrhosisAutoimmune Liver Disease +21

Ribavirin dose reduction raises relapse rate dose‐dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alpha‐2b plus ribavirin

Naoki Hiramatsu, Tsugiko Oze, Takayuki Yakushijin, +25

Journal of Viral Hepatitis

HepatologyHepatitis CRibavirin ExposureViral HepatitisRelapse Rate +13

Liver stiffness measurement by acoustic radiation force impulse is useful in predicting the presence of esophageal varices or high-risk esophageal varices among patients with HCV-related cirrhosis

Naoki Morishita, Naoki Hiramatsu, Tsugiko Oze, +9

Journal of Gastroenterology

Medical UltrasoundHepatologyLiver Stiffness MeasurementAbdominal ImagingHepatitis +7

Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection

Mika Kurokawa, Naoki Hiramatsu, Tsugiko Oze, +26

Journal of Gastroenterology

Hepatitis DLong-term EffectOncologyHepatologyViral Hepatitis +8

Indications and limitations for aged patients with chronic hepatitis C in pegylated interferon alfa-2b plus ribavirin combination therapy

Tsugiko Oze, Naoki Hiramatsu, Takayuki Yakushijin, +23

Journal of Hepatology

Pegylated InterferonHepatologyHepatitis CViral HepatitisAntiviral Therapy +7

Association of enhanced activity of indoleamine 2,3-dioxygenase in dendritic cells with the induction of regulatory T cells in chronic hepatitis C infection

Koyo Higashitani, Tatsuya Kanto, Shoko Kuroda, +14

Journal of Gastroenterology

InflammationEnhanced ActivityViral HepatitisImmune RegulationImmunology +9

Incidence and risk factors of hepatocellular carcinoma change over time in patients with hepatitis C virus infection who achieved sustained virologic response

Ryoko Yamada, Naoki Hiramatsu, Tsugiko Oze, +24

Hepatology Research

Should aged patients with chronic hepatitis C be treated with interferon and ribavirin combination therapy?

Naoki Hiramatsu, Tsugiko Oze, N. Tsuda, +7

Hepatology Research

Baseline quasispecies selection and novel mutations contribute to emerging resistance-associated substitutions in hepatitis C virus after direct-acting antiviral treatment

Yugo Kai, Hayato Hikita, Naoki Morishita, +19

Scientific Reports